NCT01494272

Brief Summary

Caudal epidural analgesia (caudal block)is used in standard pediatric anesthesia practice. It has been shown to be effective in managing postoperative pain in children undergoing abdominal and infraumbilical surgery (Tobias et al 1994). Furthermore, studies have shown that children receiving caudal blocks have secondary benefits such as lower narcotic and anesthetic requirements, more rapid awakening from general anesthesia, decreased time to discharge home, and fewer pain-related behaviors postoperatively (Conroy et al 1993, Tobias et al 1995, Tobias 1996). This proposed study involves the use of a caudal block in children undergoing elective inguinal herniorrhaphy or orchiopexy to evaluate the role of preemptive analgesia in pediatric pain management. We hypothesize that by inhibiting peripheral pain receptors with a caudal block before the onset of a painful stimulus, we can decrease central nervous system sensitization and reduce postoperative analgesic requirements

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jun 2012

Typical duration for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 15, 2011

Completed
1 day until next milestone

First Posted

Study publicly available on registry

December 16, 2011

Completed
6 months until next milestone

Study Start

First participant enrolled

June 1, 2012

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2014

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2015

Completed
Last Updated

November 25, 2015

Status Verified

November 1, 2015

Enrollment Period

1.8 years

First QC Date

December 15, 2011

Last Update Submit

November 23, 2015

Conditions

Keywords

caudal epidural analgesiaelective circumcisionelective inguinal herniorrhaphy

Outcome Measures

Primary Outcomes (1)

  • Usage of pain medications

    over 24 hours

Secondary Outcomes (1)

  • Pain scores

    At various intervals for first 24 hours

Study Arms (3)

Group CB (Caudal Before-study group)

This group will receive caudal ropivacaine and epinephrine after induction of general anesthesia prior to surgical incision

Caudal After (CA)-control group

This group will receive caudal ropivacaine with epinephrine after completion of surgery but before emergence from anesthesia

Local Infiltration After (LIA) control group

This group will receive local infiltration of ropivacaine around the surgery site at the conclusion of surgery but before emergence from anesthesia

Eligibility Criteria

Age2 Months - 2 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

Children under 2 years of age having an elective inguinal herniorrhaphy or orchiopexy.

You may qualify if:

  • Age 2 months to 2 years
  • Weight 25kg or less
  • ASA class 1, 2, 3
  • Elective inguinal herniorrhaphy or orchiopexy

You may not qualify if:

  • Contraindications to caudal epidural analgesia
  • parent's refusal
  • skeletal or spinal cord anomaly
  • coagulopathy
  • infection at the insertion site
  • ongoing bacteremia
  • allergy to ropivacaine

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Loma Linda University Medical Center

Loma Linda, California, 92354, United States

Location

Loma Linda University Outpatient Surgery Center

Loma Linda, California, 92354, United States

Location

MeSH Terms

Conditions

Hernia, Inguinal

Condition Hierarchy (Ancestors)

Hernia, AbdominalHerniaPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Officials

  • Shannon Mulder, MD

    Loma Linda University Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
M.D.

Study Record Dates

First Submitted

December 15, 2011

First Posted

December 16, 2011

Study Start

June 1, 2012

Primary Completion

April 1, 2014

Study Completion

May 1, 2015

Last Updated

November 25, 2015

Record last verified: 2015-11

Locations